Introduction
This paper builds upon and extends existing studies of scientific and technological specialisation by proposing a unifying theoretical framework to compare sectoral knowledge bases across countries.
In conducting this comparison, we elaborate upon the large body of literature that analyses National Systems of Innovation -NSI (Lundvall, 1992; Nelson, 1993) . A NSI is defined as 'being comprised of those elements of social organisation and behaviour, and the relationships among them, that are either located within or rooted inside the borders of a national state, and that interact in the production, diffusion and use of new, and economically useful knowledge' (David and Foray, 1995) . The concept of NSI has gained wide popularity well beyond the boundaries of the academic community as it became (often unwillingly) entangled with 'techno-nationalistic' positions that have animated the industrial policy debate throughout the 1980s and 1990s. As stressed by David and Foray (1995) , such positions are based upon two related (and nowadays widely-held) assumptions. First, technical capabilities lie at the core of a country's international competitiveness.
Second, the development of such capabilities is influenced by issues of national localisation and is manageable via proper government action.
Recent research has challenged the relevance of the national dimension. In particular, it stresses that firms and researchers are entangled in thick networks of international relationships that cut across national boundaries. NSIs are under increasing strain, as large firms' R&D activities are progressively internationalised. Such internationalisation is caused by emerging imbalances between what a country science base has to offer and the knowledge requirements of innovative processes.
However, despite their undeniable increase, R&D linkages have not developed on a global scale, but rather involve mainly US, EU and, to a lesser extent, Japanese firms (Patel and Pavitt, 2000) .
If R&D activities are becoming increasingly internationalised, but not 'globalised', it is vital to understand why specific countries lie at the core of such international networks. Standard explanations refer to a number of factors considered to be key determinants of 'national competitiveness' (Porter, 1990) . Following a well-established tradition (Fagerberg, Guerrieri, and Verspagen, 1999) , this paper accepts that a country's 'specialisation' pattern in specific scientific and technological fields plays a key role: firms establish R&D facilities for which they perceive they have the relevant capabilities. However, most of the studies that empirically explore specialisation patterns at country level focus on a rather narrowly defined concept of 'specialisation'. The emphasis falls squarely on the fields in which countries and/or firms patent. Classic specialisation studies focus on the cumulative evolution of countries' technological capabilities. In most cases scientific specialisation is not analysed. Moreover, the stability of specialisation patterns over time (what we will term 'knowledge persistence') is a well-established result, but persistence and cumulativeness are not the only dimensions relevant to a study of knowledge bases.
It is well known that design and development activities capture a relevant share of the R&D funded by companies (Rosenberg, 1994) . A country's knowledge base may have a strong science base but lack the engineering capabilities to embody scientific results in profitable products. Or it can have strong development capabilities that are not robustly supported by basic scientific knowledge.
Different typologies of knowledge are complementary and interrelated. A strong presence in each typology of research induces an easier multidirectional flow of knowledge that can facilitate the production of successful innovation. Micro-level innovation studies strongly support this view, e.g. Pisano (1997) . Therefore, what type of research (e.g. basic vs. engineering-oriented) is carried out in each field becomes a key issue.
The chief aim of this paper is to develop a framework to analyse knowledge specialisation both over time and across research typology. We put forward this framework as a way to approach questions related to industries' decisions to source knowledge internationally. In particular, we wish to link these decisions to specific characteristics of the sectoral knowledge base that act as source. The paper identifies, at sectoral level, the relevant dimensions that make the comparison of different countries' knowledge bases a meaningful exercise, and then operationalises them. Particular attention is devoted not only to examining whether each country specialisation is stable over time (knowledge persistence), but also whether specialisation by field is similar across different typologies of research (knowledge integration).
The operationalisation of these two dimensions is based upon the design of a comprehensive data set of peer-reviewed papers that was obtained by combining the standard ISI classification by science field with the CHI classification by type of research (i.e. Applied Technology & Engineering, Applied Research and Basic Research). The result is an original data set encompassing some 630,000 papers published in eleven different sub-fields of chemistry and pharmacology between 1989 and 1996. The limitations of peer-reviewed publications as an indicator of knowledge bases will be discussed. This data set will allow for a quantitative analysis of the characteristics and evolution of the specialisation profile of the four largest European countries (the UK, Germany, France and Italy), the EU as a whole, the US and Japan.
This dataset is analysed in combination with the PACE survey (Arundel, van de Paal, and Soete, 1995) . The results of the PACE questionnaire pinpoint the pharmaceutical industry as a highly internationalised industry. PACE shows not only that EU R&D managers in the pharmaceutical sector value the results of public research, but also that they rely upon international research much more than those in the chemical sector and the other manufacturing industries. Also, PACE stresses that the pharmaceutical industry relies more on North American research than on EU research. The questions that demand explanation is why EU pharmaceutical firms rely to such a great extent on North American research. What makes it attractive to EU firms? In attempting to answer these questions, we discuss some evidence related to the existence of a 'European Paradox' in the case of traditional pharmaceuticals. In order to do so, we compare the sectoral knowledge base across countries by developing a grid designed along the two dimensions identified above: integration and persistence.
The paper is organised as follows. Section 2 discusses the concept of knowledge persistence and integration. Section 3 presents an empirical exploration of the concepts developed in the previous section in the case of the pharmaceuticals and chemicals knowledge bases. Finally, Section 4 offers concluding observations and raises a few policy issues.
Towards a theoretical framework of knowledge specialisation
Although the recent literature has devoted increasing attention to analysis of the economics of science and its implication for the innovation process (Dasgupta and David, 1994; Mansfield, 1991; Narin et al., 1997) , the analysis of national science and technology specialisation profiles has remained so far largely independent. Despite token acknowledgement of the complexity and intricacy of the relationships between the science and the technology domains, specialisation studies tend to focus on either science or technology. The former traditionally relies on bibliometric indicators: The latter on patent studies. The former is dominated by sociologists of science The latter by economists that study technical change. The 'rhetoric' of the linear model still determines the intellectual division of labour in this area of research. This paper represents a first step toward the redefinition of such division of labour. We achieve this by complementing the analysis of knowledge specialisation over time with an analysis of knowledge specialisation across type of research. First, we briefly review a few classic specialisation studies developed in the historical, sociological and economic literature to stress the cumulative and path dependent process of knowledge production and accumulation. The concept of knowledge persistence (i.e. of specialisation over time) is based upon these notions. Second, micro level analysis of technical change will inspire the introduction of the concept of knowledge integration (i.e. specialisation across type of research). In this respect, and somewhat paradoxically, this paper is a first attempt to develop the 'macro-foundations of innovation management studies'.
We will argue that the combined study of specialisation, in terms of both specialisation over time and specialisation across types of research, enables analysts to start addressing issues such as why different industries utilise national vs. international sources of knowledge to different extents.
Specialisation patterns over time: knowledge persistence
Research in the history of science has stressed the cumulative and social aspects of scientific endeavour. Historians have provided a number of accurate case histories that reveal how the accumulation of results over time influences the rate and direction of the discovery process. For instance, Conant and Nash (1964) describe the process of accumulation of quantitative results in physics that led to Lavoisier's revolution in modern chemistry. Such a process did not entail the substitution of inaccurate explanations by more accurate ones; rather, it entailed the reconceptualisation of existing findings to deliver a new, more general explanation. In addition, it is particularly interesting that scientific advancement is often focussed on a 'common frontier.' The evidence for this is the incidence of multiple discoveries that Merton characterised as endemic rather than isolated features of science (Merton, 1965) . On a different tack, the cumulative development of science has been studied following the seminal work of Price (1963) . Price sketches a macro 'growth of knowledge' approach that highlights the acceleration of scientific publication that accompanied the growth of the scientific community. This approach is probably more congenial to economists who can put forward a number of established theoretical propositions to explain Price's empirical results. First, the increasing size of the scientific community would enable increasing division of labour and generate network externalities so that 'increasing returns' in scientific endeavour would be activated. Second, the growth of the scientific community stimulates the race for priority in discovery. This would create a powerful incentive to publish more prolifically in order to share some credit for 'discovery.' Scientific advance would then occur in smaller steps with greater overlap and duplication. Third, as the scientific community grows it becomes more difficult to assess individual contributions and there is an incentive to produce more publications in order to make claims about 'productivity'. As the three mechanisms do not exclude each other, cumulativeness is the most likely outcome.
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On the strength of the above literature, studies in the fields of bibliometrics and the sociology of science have analysed the scientific base of individual countries in terms of publications share (Braun et al., 1995) . However, the analysis of absolute shares does not allow for meaningful crosscountry comparisons. Only recently has the methodology used to analyse technological specialisation (based upon relative specialisation indicators) been applied to the publication output of countries in an attempt to develop a comparative analysis of scientific specialisation patterns (European Commission, 1997; Geuna, 2001; Godin, 1994; OST, 1998; Pianta and Archibugi, 1991) ,
The works of Soete (1981) , Pavitt (1989) and Cantwell (1989) provide the building blocks for the analysis of stability of technological specialisation patterns at the country level. Following these studies a large body of literature has been devoted to the study of technology and trade specialisation. The analysis of country-level technological specialisation patterns is nowadays a commonly accepted methodology to study the relationship between innovation and performance in terms of international trade and/or growth. In a nutshell, as technical change is a cumulative process that generates clusters of innovations, 'it is not indifferent in which technological areas countries are specialised' (Meliciani, 2001) . Different technical fields are characterised by different degrees of innovative opportunities and appropriability conditions (Carlsson, 1997, Malerba and Orsenigo, 1997) . Furthermore, the learning processes that underpin technical change tend to be localised and cumulative (Pavitt, 1992) : it is easier to learn in the proximity of what one already knows, so to speak. Therefore, if one is specialised in the 'wrong' (i.e. low opportunity) technical or scientific fields, one should not expect to be able to refocus one's own specialisation pattern in the short term.
Trade and growth indicators will reflect such 'bad' specialisation. Scholars of technical change have therefore devoted much effort to matching technological specialisation indicators and countries' growth indicators (Fagerberg, Guerrieri, and Verspagen, 1999) . Although there is some consensus about the importance of the knowledge base (or science base) of a country in the process of economic growth, the empirical and theoretical analyses have focused almost entirely on technology (especially patents) and generally do not attempt to provide a measurement for the scientific base of the country. The work of Archibugi and Pianta in the early 1990s (see for example Archibugi and Pianta (1992) ) is one of the rare examples of the combination of patent studies and bibliometric analysis to examine national specialisation in the EU countries. Expanding upon the bodies of literature discussed above, we define knowledge persistence as the stability of the knowledge specialisation pattern over time.
Specialisation across research typologies: knowledge integration
Persistence and cumulativeness are not the only dimensions relevant to a study of the knowledge bases of firms or countries. Micro level studies of technical change have highlighted how the integration of different types of research plays a crucial role in the process of innovation. Integration issues have been studied at length in the innovation management literature. Pavitt (1998) stresses that the key role played by modern firms is mapping (integrating) an increasing range of relevant disciplines to products. Integration efforts at firm level have been thoroughly discussed by a number of authors. Granstrand, Patel, and Pavitt (1997) study the distributed capabilities that enable firms to monitor and integrate technologies. Iansiti (1998) analyses integration issues in the mainframe industry. Prencipe (1997) studies similar problems in the aero-engine industry. Engineering disciplines are commonly stressed as powerful, although often overlooked, enablers of such integration. They would provide the problem-solving techniques to handle complex problems by decomposing them into simpler sub-tasks, solving these latter and then integrating them back into a a consistent whole. For instance, Patel and Pavitt (1994) study the pervasiveness of mechanical engineering skills across a variety of sectors. Landau and Rosenberg (1992) analyse chemical engineering as the key engine of growth in the modern chemical industry. Vincenti (1990) stresses the key role played by engineers and engineering sciences in solving the problems and finding the explanations that led to the birth of the aircraft industry. Pisano (1996 Pisano ( , 1997 studies in detail a sample of pharmaceutical development projects in order to conclude that success is related to the capability to carry out, in a co-ordinated and timely manner, a number of activities that go well beyond the traditional boundaries of the R&D laboratory. The development of economically viable routes to produce drugs on an industrial scale is fraught with complex engineering issues, particularly when new, untested routes are explored.
Nevertheless, more aggregated studies remain focused on indicators that do not allow one to analyse whether the country possesses a strong knowledge base, that spans basic, applied and development research activities, in any specific sector. A country's sectoral knowledge base may have a strong science base but lack the engineering capabilities to embody scientific results into profitable products or it can have strong development capabilities but a not sufficiently robust base of scientific knowledge. If either is the case, firms may need to source the lacking capabilities from where they exist, e.g. abroad. This view is not based on the simple linear model that sees basic research as the source of the whole knowledge that is then transformed into technology. On the contrary, what we want to stress here is that the various typologies of knowledge are complementary and interrelated. A strong standing in each typology of research induces an easier multidirectional flow of knowledge that can facilitate the production of successful innovation.
Such intuition is consistent with the theoretical framework developed, for instance, by David and Foray (1995) , whereby they argue that 'an efficient system for accessing and distributing knowledge will increase the social value of the knowledge produced … by … increasing the likelihood of forming new combinations'. Consistent with the results of micro-level studies of technical change, we argue that the successful exploitation of such combinations requires the existence of capabilities spanning a range of disciplines that go beyond the traditional boundaries of scientific endeavour.
Knowledge bases that are too narrowly focused around core scientific disciplines (with no competencies in the related, but different, engineering sciences) may fail to close the feed-back loop between the science and the technology domains. Such failure would seriously hamper the 'distribution power of the system' (David and Foray, 1995) . In other words, in order to close the feed-back loop between the science and the technology domains, countries (as well as firms) need to maintain distributed (rather than narrowly focused) competencies at sectoral level. As a national bias seems to exist in terms of the effectiveness of the linkages between business practitioners and academic research Geuna, 2001, Malo and Geuna, 2000; and Narin et al., 1997) , it is likely that such a bias exists also with respect to the linkages between scientific and engineering communities. Thus, particular attention should be devoted not only to examining whether each country's sectoral specialisation is stable over time (knowledge persistence), but also whether each country's sectoral specialisation cuts across different types of research (knowledge integration). A sectoral knowledge base with high knowledge integration would have a similar specialisation by field across different typologies of research.
To conclude, what we propose is a simple analytical framework capable of combining the analysis of specialisation profiles over time with the specialisation across type of research. This framework, built upon the notions of knowledge persistence and knowledge integration, should be useful to shed light on the 'morphological' characteristics of different countries' knowledge bases in certain sectors, and thus help explain firms' international knowledge sourcing decisions. Table 1 below summarises the discussion. In what follows, we will argue that this typology can be usefully deployed to study a number of issues related to the characteristics and evolution of countries' sectoral specialisation profiles, as well as firms' decisions about where to source useful knowledge and capabilities. {Table 1 about here} With respect to any specific sector, a country can be positioned in one of the four quadrants of the 2x2 matrix of knowledge specialisation (Table 1) . Country A, in the top right quadrant is characterised by a persistent pattern of scientific specialisation and high level of knowledge integration. In the fields where it is positively specialised, Country A has developed capabilities in basic, applied and engineering research. Country B (top left quadrant) would be persistently specialised in one or more fields, but its capabilities would be focused on, say, basic research only.
Country C (bottom right quadrant would be characterised by integrated, although somewhat erratic, scientific and technological skills. Finally, Country D would be both erratic and unfocused in terms of research types: the fields of positive specialisation would change frequently and would be different in the different types of research.
An Empirical Exploration of Knowledge Persistence and Knowledge Integration
In this section, we argue that by introducing the notion of 'knowledge integration' alongside the more traditional one of 'persistence' we can actually explore quantitatively problems that are only partially answered by more traditional specialisation studies. Specifically, in this paper we focus upon two main issues. First, we are interested in understanding the differences between patterns of internationalisation of knowledge sourcing activities pursued by different industries. Or, in other words, why firms in different industries appear to rely more on foreign innovation systems.
Traditional explanations of this type of behaviour stress that firms go abroad whenever they (think they) can access 'better' capabilities relevant to their innovative and manufacturing efforts (Cantwell, 1995) . Implicitly, these explanations assume that firms go abroad when their home knowledge base is not specialised in the 'right' fields. Second, the notion that a 'European paradox' exists has gained wide support in the public policy arena (European Commission, 1996) . According to this position, in some sectors EU firms would be very good at developing new ideas, but would tend to fail in exploiting them commercially. Something would be 'missing' in the EU system of innovation (or its national components) that would leave EU firms at disadvantage against their US counterparts. While the anecdotal evidence is abundant, rigorous empirical studies to prove (or disprove) the existence of such a problem are scant. Tijessen and van Wijk (1999) provide one of the few systematic efforts to solve this question with robust empirical data in the specific case of the ICT sector.
To contribute to this debate, we operationalise our framework in the case of the international pharmaceutical industry, using the chemical industry as a yardstick. The pharmaceutical industry is an interesting case for our purposes for a number of reasons. First, it relies heavily on basic highly codified research at the forefront of human knowledge, thus the scientific and technological knowledge base contributes to the development of this industry in a crucial way. Second, the pharmaceutical industry appears to be one of the most internationalised manufacturing sectors, not only in terms of product markets, but also, specifically, in terms of the knowledge sourcing strategies pursued by the major players (Patel and Pavitt, 2000) . Third, and consistent with the previous point, the results of the PACE survey (Arundel, van de Paal and Soete, 1995) 2 show that 'general and specialised knowledge' produced by public research institutes is particularly valuable to pharmaceutical firms (much more than to other manufacturing sectors), and that these firms consider scientific publications to be the key channel to internationally access this knowledge. Thus, publications can be used as a proxy for the measurement of the characteristics of persistence and integration of the knowledge base. simultaneously make inter-country and inter-sectoral comparisons. Countries differ in the nature and extent of their development of specific industries. Since these differences are very difficult to capture, it is useful to choose industries that share a common knowledge base as the point of reference, but that rely on knowledge generated outside their home countries to different extents. Therefore, differences in sectoral behaviour may be related to the country-specific characteristics of the foreign NSI that firms approach. Needless to say, the knowledge bases of the chemical and pharmaceutical industries differ greatly. The key difference is denoted by the increasing reliance of pharmaceuticals on biology and biotechnologies, rather than chemistry (Gambardella, 1995; Orsenigo, 1989; Pisano, 1997) . The chemical sector seems not to have seriously explored the potential of biotechnologies, although recent development in combinatorial chemistry and biology provide evidence of the possibility for convergence (Malo and Geuna, 2000) . By not considering the biotechnological knowledge base, one can analyse that portion of the pharmaceuticals knowledge base that relies on the more traditional chemical processes. Such a knowledge base is fairly similar to the one the chemical industry relies on.
International knowledge sourcing activities and the European paradox
The results of the PACE survey reveal the sources of the public research activities most useful to EU R&D managers and the specific channels used to find out about such research activities.
Studying the frequency with which EU firms source knowledge from different regions (with respect to each method for learning about public research) reveals the geographical origin of the most useful research activities (Table 2) .
{Table 2 about here}
In the chemical industry, respondents obtained the results of research conducted by public research institutes or universities from the whole range of sources at levels similar to those for all the sectors combined. However, a few particularities are worth mentioning. Chemical firms obtain information from conferences in their own country and those in other European countries with the same frequency (about 88% of the respondents). In the case of publications, informal contacts and hiring, respondents being assigned to other European countries and North America, similar shares. Also, and incomplete proxy of the knowledge base, more inclusive indicators or combinations of indicators should be developed in the future to operationalise the interpretative framework. these shares are lower than those assigned to the firms' own country (respectively about 83% for publications, 67% for informal contacts and 34% for hiring).
As for the pharmaceutical industry, the home country localisation effect tends to vanish. About 90% of respondents obtained information through publications, informal contacts and conferences within their own country, other European countries and North America with only a smaller percentage receiving information from Japan. When EU R&D managers source public research results, they approach the North American science system, the EU and domestic sources with a similar frequency. In particular, North American papers are used with the same frequency as home country publications (95%) and more frequently than papers from other EU countries (92%).
The behaviour of the pharmaceutical industry is of particular importance, if only because it is widely considered as one of the main areas of strength for the EU (Sharp, Patel, and Pavitt, 1997) .
However, despite past successful performance, the EU industry itself seems to be rather pessimistic about the future (Sharp, Patel, and Pavitt, 1997) . Rising levels of R&D, decreasing profit margins and the struggle to refocus research efforts toward biotechnologies have been undermining the competitive position of the industry. US pharmaceutical companies are often considered to be way ahead of their EU competitors, particularly with respect to the adoption of biotechnologies.
It is often argued that the comparative success of the US industry is related to its capability to effectively transform the results of basic research into blockbuster drugs, rather than its ability to generate such results per se. In this respect, a European paradox is commonly evoked to stress the gap existing between the seemingly good performance of EU basic research and the relatively bad commercial performance of EU firms (when compared to US competitors). European firms would not be particularly good at transforming brilliant ideas into successful products. While most observers now agree on this last point, explanations of the causes of the phenomenon are in short supply. Generally speaking, the firms themselves are often blamed for not applying sensible management practices that would enable them to fully exploit the wealth of insights provided by the EU system of innovation and its national components. British firms would be too short sighted; German firms would be too slow in taking decisions and pursuing new research routes; French firms would be provided shelter from the pressures of the global economy by a complacent state-managed health system, and so forth.
While appealing, such propositions fail to consider the complementary possibility that there is something systematically different between the EU and the US knowledge bases that enables US firms to be more competitive and induces EU firms to look to the US scientific knowledge base for sourcing new knowledge. In the following, we operationalise our framework to interpret the results of the Pace survey and assess the anecdotal evidence about the European paradox.
Mapping and measuring countries' sectoral knowledge bases
We have examined the publication profile of different countries in the fields of chemistry and pharmacology. Following Geuna (2001) we use the Science Citation Index database of the Institute for Scientific Information to analyse the publication output of the four largest European countries, the EU, Japan and the US in the period 1989-1996 (see Geuna (2001) for a description of the data).
Eleven scientific fields relevant to the chemical and pharmaceutical industries are identified. Research. Godin (1994) , who studied a sample of large innovating firms in order to analyse the complementarities between science and technology, proposed a similar approach. He developed a database of publications that were then divided into four groups in a spectrum that varied from very applied to basic ('untargeted') research. Unlike this paper, his work focused on firm-level activities, rather than sectors.
To develop a comparative analysis of the knowledge base in chemistry and pharmacology, the relative specialisation of a country is studied. The symmetric Relative Specialisation Index (RSI) (see Appendix I for methodological issues concerning the RSI) is calculated on the basis of data from the SCI database for six countries and the EU, eleven scientific fields and three research areas between 1989 and 1996 (Balassa, 1965; Soete, 1981) . The statistical results are used to operationalise the theoretical framework of knowledge specialisation for the pharmaceutical and chemical industry.
Knowledge persistence (stability of specialisation patterns over time)
In the 8 year period under examination the specialisation of the EU and the six countries considered has changed, in some cases in a substantial way. To verify the stability (or lack thereof) of overall specialisation patterns we examined how all the eleven specialisation indices changed over time.
Following the work of Pavitt (1989) , we have calculated the Pearson correlation coefficient for each country at the start and at the end of the period considered. Positive and significant coefficients would hint at the cumulative and path dependent nature of knowledge accumulation processes. We discovered that the knowledge specialisation in France, Germany, the UK, Japan and the US is positively correlated in the two periods, while no significant correlation was found for Italy and the EU. The UK, Japan and the US, with a Pearson coefficient higher than 0.8 and a significance level of 1%, are the three countries with the highest persistence in scientific specialisation.
Furthermore, in order to analyse the path of specialisation or despecialisation of a country, we regressed the symmetric specialisation index in 1996 on the 1989 value, country by country. Such a methodology was originally proposed by Cantwell (1989) and consists of a simple country-bycountry regression at two different points in time. The dynamic path cannot then be studied. Also, nothing can be said about the determinants of the initial pattern of specialisation. Despite this limitation, this methodology has been widely used in specialisation studies. Its main advantage is its simplicity.
If the β coefficient equals 1, then the country specialisation pattern has remained unchanged over the period. If β > 1 then the country is increasing its positive specialisation in fields where it was already specialised. If 0 < β < 1, the country has decreased its negative specialisation in those fields where it was negatively specialised at the beginning of the period (or decreased its positive specialisation where it was positively specialised). In all cases, variations in specialisation occur in a cumulative way, as β > 0. In the case that β is not significantly different from zero, the hypothesis that changes in specialisation are either not cumulative or are random cannot be excluded. If β is negative we are witnessing a process of reversion in the specialisation. The case where β >1 is often referred to as β-specialisation (Dalum, Laursen, and Villumsen, 1998) . Cantwell (1989: 31-32) argues that β > 1 is not a necessary condition for increasing specialisation.
Therefore, we have also analysed the so-called σ-specialisation (Dalum, Laursen, and Villumsen, 1998) . The dispersion of a given distribution does not change if β = R, if β > R the specialisation increases (σ-specialisation) and if β < R the specialisation decreases (σ-specialisation).
For each of the countries we ran regressions on all fields, basic research only, applied research only, applied technology & engineering research only. For the most general regression, we found that Germany is the country with the most stable specialisation pattern (β = .96, R = .724). Italy and EU do not have significative coefficients. All the other countries despecialise cumulatively (i.e. 0 < β < 1) in terms of both β and σ-specialisation, with the UK (β = .843, R = .897) being the most cumulative, followed by the US (β = .779, R = 852), Japan (β = .659, R = 926) and France (β = .42, R = 799). All coefficients are significative at the 1% level (2% for Germany). In terms of basic research only, only the US, Japan and the UK have β coefficients with a significance level higher than 5%, respectively 1.04 (1%), 0.95 (2%) and 0.44 (4%). The US with both β >1 and β/R >1 increased specialisation in sectors where it was already specialised, and became less specialised where initially specialisation was low. Japan with both β ~ 1 and β/R ~ 1 showed a high stability in its specialisation patterns. In particular, the US deepened its specialisation in fields related to the pharmaceutical industry: Medical Chemistry (C6) and Pharmacology (C10). The four largest European countries saw an increase in the dispersion of their basic research specialisation. EU countries, especially Germany and France, show a tendency to remain more focused on traditional chemistry fields. Table 3 
Knowledge integration (specialisation across research typology)

A taxonomy of knowledge specialisation
By combining the results on persistence and integration, it is possible to map the science and engineering bases of different countries on a two-dimensional space that summarises the results sketched above. We have mapped the indicator of integration above on the horizontal axes and the indicator of persistence on the vertical one. For persistence, we have used the results of the regressions for all chemistry and pharmacology fields, first and last year, country by country. We have also used the coefficients for Italy and the EU although, as stated above, they are not significative. As all coefficients are 0 < β < 1 (β-despecialisation), but Germany's (whose β equals 1), we set 0.5 as the threshold. For integration, we have used the simple indicator sketched above.
The threshold between high and low integration is given by the arithmetic average of the indicator (0.22). Table 4 reports the result of such combination.
{Table 4 about here}
It is quite apparent that the US and Germany combine high levels of both integration and persistence. France, despite a high level of integration, exhibits low persistence over time. Neither
Japan nor the UK shows any integration, but the UK is more stable in its specialisation pattern. Italy and the EU lie somewhere in between. The EU as a whole is characterised by both average integration and low persistence (this latter coefficient was not significative in the regression). Italy appears to be relatively integrated, but exhibits low persistence (Italy's coefficient for persistence is not significant).
It is worth combining the results of this taxonomy with the analysis of the specific fields of specialisation listed in Table 3 . Despite the high persistence and integration exhibited by both the US and Germany, their specialisation profiles appear to be very different. In particular, Germany's specialisation revolves around traditional chemistry fields, such as Crystallography (C4) and Inorganic Chemistry (C5). The US is instead specialised in those fields more directly related to pharmaceuticals: Medical Chemistry (C6) and Pharmacology and Pharmacy (C10). The other EU countries studied also are more specialised in 'chemistry for chemicals', rather than pharmaceuticals. Furthermore, it is evident from the regressions we ran by type of research that the EU countries' specialisation in Medical Chemistry and Pharmacology decreases as we move away from development type research up to applied and then basic research.
Such results are consistent with other studies of specialisation carried out that rely on traditional methodologies. So, for Germany specialisation in 'traditional' chemistry (i.e. inorganic and organic) is confirmed by Sternberg (2000: 98) who also highlights the German disadvantage in medical sciences. OST (1998) confirms both the integration of the German pattern of specialisation and its focus on chemistry. Furthermore, the UK seems to be more specialised in medical research than France and Germany. OST (1998) also confirms the strong EU specialisation in chemistry and its relative disadvantage (in terms of publications) in biology (basic research).
These different specialisation profiles hint at a possible explanation of the results of the PACE questionnaire. The PACE survey revealed that public research carried out in North America was valued and used extensively (even more than public research carried out in other European countries) by the largest EU R&D firms in the pharmaceutical sector. The PACE questionnaire does not allow speculation about why this happens, though. We argue that the reliance of EU firms on the (Table 3) . Also, the results of the regression by type of research clearly show that only the US and Japan are increasing their specialisation in basic research. No clear pattern is discernible for EU countries except for the UK, which is β-despecialising. Therefore, these data do not allow us to talk about a 'European paradox', according to which EU firms would not be capable of exploiting an efficient basic research system because of lack of 'development' capabilities. Our data seem to point to the fact that these types of capabilities do exist. What is missing is the basic research bit, with the result that EU pharmaceutical firms have to source research results in the US. Consistently, the pattern of sourcing is different when chemical firms are considered, as their home country knowledge bases seem more capable of providing basic research capabilities.
Despite the limitations of the data and the simplicity of this analysis, the location of different countries along the grid defined by the measures of persistence and integration matches a few things we know about the institutional structure of each country, and also raises some interesting questions. For instance, the results concerning the 15 EU countries as a whole are hardly surprising.
A EU-wide system of innovation is still in formation. National industrial and S&T policies still heavily influence country-level specialisation patterns, preventing them from converging toward a homogeneous whole.
Conclusions
The evolution of country-level sectoral specialisation has been conceptualised by discussing knowledge persistence and knowledge integration. Persistence is related to the evolution of specialisation over time. It hints at the cumulative, path-dependent nature of the learning processes.
Integration is related to the evolution of specialisation across different typologies of research. It hints at the complex, non-linear interdependencies that link the scientific and technological domains. The interaction of the concepts of knowledge persistence and knowledge integration provide a head start for the development of a robust conceptual framework in which to compare countries' sectoral knowledge bases. Quite importantly, the conceptualisation proposed in terms of persistence is consistent with the results of micro-studies of technical change that pinpoint learning processes as cumulative and path-dependent (David, 1985) . Also, innovation studies hint at the key role played by distributed (rather than narrowly-focused) capabilities in enabling technical change (Granstrand, Patel, and Pavitt, 1997) . This is captured by the concept of knowledge integration.
This paper represents a first attempt to operationalise this framework on the basis of a statistical analysis of a huge, original and 'purpose-built' data set that describes the scientific and engineering knowledge base in chemistry and pharmacology in the four largest European countries, the EU as a whole, the US and Japan during the period 1989-1996. Analysis of the relationships between core positive and negative specialisation, and of the typology of research (applied technology & engineering, applied research and basic research) has shown that the countries considered have different degrees of knowledge integration and knowledge persistence. Specifically, the US and Germany exhibit the highest coefficients of persistence and integration. However, the US is more heavily specialised in fields related to pharmaceuticals (i.e. Medical Chemistry and Pharmacology & Pharmacy) than Germany and the other EU countries which appear to be more specialised around traditional chemistry. These results are consistent with the views expressed by the EU R&D managers that responded to the PACE questionnaire. They stressed that public research developed in North America was particularly useful to their innovative efforts in pharmaceuticals. In contrast, domestic and EU localisation effects prevail in the case of the chemical industry.
As for the policy implications, the empirical results presented (although preliminary) allow us to put forward two main observations. First, our data set does not identify any 'European paradox' in Pharmacology. EU countries exhibit capabilities in terms of applied and engineering research, but not in basic research. Instead, the US only increases its β-specialisation in basic research in Pharmacology and Medical chemistry. No clear pattern is discernible for EU countries, with the exception of the UK, which is β-despecialising. Such lack of basic research capabilities may well explain the frequency with which EU R&D managers in pharmaceuticals approach the US knowledge base. As for chemicals, the pattern of sourcing is different. As their home country knowledge bases seem more capable of providing a more integrated pattern of research capabilities, EU chemical firms rely chiefly on their home country knowledge base and then approach the EU one. At least for Pharmacology and Medical Chemistry we found no evidence of paradoxes.
Second, our approach hints at the possibility that government can actually influence the rate of technical change by fostering the development of an 'integrated' specialisation profile. Empirically, one can identify the NSI that firms consider to be more helpful to their innovative activities (e.g. the US for pharmaceuticals), analyse it in terms of integration and then target the type of research that is lacking in the home country. We may call this the 'policy for integration' option. In fact, despite the enormous resources devoted by policy makers to the exploration of emerging technologies, 'picking the winner' remains a rather hazardous activity. The greatest successes of recent years are the unintended consequences of policies aimed at fostering other paths of research -e.g. biotechnology being the unintended offspring of US cancer research programmes and the beneficiary of military research for the bio-war (Martin, Irvine and Isard, 1990) . Which specific scientific field will be responsible for the next revolution remains very difficult to predict. We argue that our approach would not allow governments to pick the winners, but would allow them to support the development of an integrated knowledge base once a new path has emerged.
The limitations of this paper open up a number of challenging questions for future research. First, publications are very good at tracing the scientific knowledge base of a country, but are less successful as far as engineering research is concerned. Merging traditional data sets of patent activities with our data set of publications would provide a better picture of the interaction between scientific and engineering specialisation. Second, the concepts of knowledge integration and persistence can also be applied to the study of firms' knowledge bases to further confirm the consistency between micro and macro level dynamics. It is important to expand such analysis to test the existence of a correlation (causation?) between knowledge integration and knowledge persistence in certain fields on the one side, and technological and economic performances of firms and countries on the other. The qualitative indications provided by the PACE questionnaire are but a first step. Third, this analysis should be extended to a sample of 'small countries'. These could be much less integrated and persistent than large countries as they may find it more convenient (or just more feasible) to exploit the advantages of flexibility by specialising narrowly in terms of fields and/or types of research and then switching when new research trajectories emerge. Finally, on a more theoretical note, PACE reveals that firms can source knowledge not available in their home country by looking abroad. However, there are costs attached to such a choice. Traditionally, costs are related to the geographic distance between source and user. This paper hints at the possibility that there might be costs attached also to the relative position in the 'knowledge spectrum', so that the farther from a typology of research the more expensive it will be to develop knowledge exchange. 
